Literature DB >> 7690761

Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts.

M J Stutts1, S E Gabriel, J C Olsen, J T Gatzy, T L O'Connell, E M Price, R C Boucher.   

Abstract

We studied the consequences of cystic fibrosis transmembrane conductance regulator (CFTR) expression in NIH-3T3 fibroblasts as a model for the effects of virally transduced CFTR expression in non-epithelial cells. Fibroblasts were infected with a retrovirus vector that contained the human CFTR and neor cDNAs. We selected and expanded G418-resistant clones that encompassed a range of CFTR expression. CFTR-mediated Cl-conductance function was measured as whole cell current, and CFTR protein was quantitated by immunoblot analysis. Overall, there was a good relationship between CFTR protein levels and CFTR-mediated Cl- conductance. Some clones had consistently high basal levels of CFTR-mediated Cl- conductance. This variation in function was partially explained by CFTR protein levels and was not due to clonal variation in cAMP metabolism. High levels of CFTR expression were associated with depolarization of fibroblast membrane potential. The CFTR-expressing clones with the largest basally active CFTR Cl- conductances and the most depolarized membrane potentials also exhibited slower growth rates. These results suggest that potential side effects of gene replacement therapy for cystic fibrosis include functional consequences of CFTR expression in non-epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690761

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  A Perspective: Division of Lung Diseases at Fifty.

Authors:  Gail G Weinmann; Thomas L Croxton; Neil R Aggarwal; Michael J Twery; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

2.  Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator.

Authors:  Lianwu Fu; Andras Rab; Li Ping Tang; Steven M Rowe; Zsuzsa Bebok; James F Collawn
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 3.  Altered drug translocation mediated by the MDR protein: direct, indirect, or both?

Authors:  P D Roepe; L Y Wei; M M Hoffman; F Fritz
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

4.  Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?

Authors:  M M Hoffman; L Y Wei; P D Roepe
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

5.  Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling.

Authors:  Hiroko Hamai; Fannie Keyserman; Lynne M Quittell; Tilla S Worgall
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

6.  Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels.

Authors:  Beate Illek; Rosalie Maurisse; Logan Wahler; Karl Kunzelmann; Horst Fischer; Dieter C Gruenert
Journal:  Cell Physiol Biochem       Date:  2008-07-25

7.  Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator.

Authors:  J H Poulsen; H Fischer; B Illek; T E Machen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Overexpression of the cystic fibrosis transmembrane conductance regulator in NIH 3T3 cells lowers membrane potential and intracellular pH and confers a multidrug resistance phenotype.

Authors:  L Y Wei; M J Stutts; M M Hoffman; P D Roepe
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

9.  Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor.

Authors:  T Ferkol; J C Perales; E Eckman; C S Kaetzel; R W Hanson; P B Davis
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.

Authors:  M A Izquierdo; J J Neefjes; A E Mathari; M J Flens; G L Scheffer; R J Scheper
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.